Low Dose Methimazole in the Long-Term Management of Graves’ Disease: Small doses, big benefits

Journal Article Accepted manuscript Low Dose Methimazole in the Long-Term Management of Graves' Disease: Small doses, big benefits Get access Danilo Villagelin, MD, PhD, Danilo Villagelin, MD, PhD Pontifical Catholic University of Campinas (PUC-Campinas), School of Life Sciences, Faculty of Medicine, Campinas 13034-685, SP, Brazil https://orcid.org/0000-0002-4173-7258 Search for other works by this author on: Oxford Academic Google Scholar David S Cooper, MD David S Cooper, MD Division of Endocrinology, Diabetes, and Metabolism, The Johns Hopkins University School of Medicine, Baltimore 21287, MD, USA [email protected] https://orcid.org/0000-0002-9406-6400 Search for other works by this author on: Oxford Academic Google Scholar The Journal of Clinical Endocrinology & Metabolism, dgaf503, https://doi.org/10.1210/clinem/dgaf503 Published: 10 September 2025 Article history Received: 29 August 2025 Accepted: 03 September 2025 Published: 10 September 2025